X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7318) 7318
Publication (1125) 1125
Book Chapter (203) 203
Book Review (146) 146
Book / eBook (58) 58
Conference Proceeding (16) 16
Dissertation (6) 6
Government Document (3) 3
Data Set (2) 2
Journal / eJournal (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4015) 4015
index medicus (3898) 3898
animals (2745) 2745
cns (2308) 2308
female (2178) 2178
male (2125) 2125
neurosciences (1868) 1868
oncology (1671) 1671
central-nervous-system (1456) 1456
central nervous system (1374) 1374
mice (1289) 1289
adult (1214) 1214
middle aged (1133) 1133
brain (1095) 1095
clinical neurology (1030) 1030
cancer (936) 936
chemotherapy (891) 891
aged (878) 878
primary cns lymphoma (851) 851
nervous system (812) 812
neurology (774) 774
article (733) 733
immunology (730) 730
research (695) 695
analysis (691) 691
rats (687) 687
adolescent (661) 661
child (646) 646
medicine & public health (642) 642
hematology (606) 606
cell biology (587) 587
biochemistry & molecular biology (583) 583
expression (572) 572
care and treatment (529) 529
neurons (523) 523
multiple sclerosis (508) 508
multiple-sclerosis (501) 501
prognosis (500) 500
lymphomas (492) 492
radiotherapy (487) 487
pharmacology & pharmacy (481) 481
survival (477) 477
mice, inbred c57bl (466) 466
inflammation (464) 464
child, preschool (459) 459
health aspects (454) 454
magnetic resonance imaging (451) 451
cells, cultured (449) 449
treatment outcome (449) 449
therapy (442) 442
children (438) 438
diagnosis (435) 435
tumors (428) 428
retrospective studies (426) 426
gene expression (422) 422
immunohistochemistry (415) 415
proteins (407) 407
pediatrics (396) 396
disease models, animal (375) 375
blood-brain barrier (364) 364
stem cells (364) 364
risk factors (362) 362
pathology (354) 354
infant (352) 352
methotrexate (348) 348
surgery (348) 348
antineoplastic combined chemotherapy protocols - therapeutic use (346) 346
physiological aspects (346) 346
disease (344) 344
aged, 80 and over (342) 342
multidisciplinary sciences (340) 340
brain tumors (335) 335
medicine (335) 335
non-hodgkins-lymphoma (334) 334
young adult (326) 326
brain - metabolism (322) 322
cells (321) 321
microglia (310) 310
lymphoma (308) 308
combined modality therapy (305) 305
brain - pathology (302) 302
time factors (300) 300
cerebrospinal-fluid (299) 299
rodents (299) 299
experimental autoimmune encephalomyelitis (295) 295
biomedicine (287) 287
in-vivo (281) 281
activation (277) 277
research article (273) 273
transplantation (272) 272
differentiation (270) 270
brain neoplasms - pathology (260) 260
in-vitro (258) 258
high-dose methotrexate (256) 256
apoptosis (254) 254
mice, knockout (254) 254
signal transduction (253) 253
central nervous system neoplasms - drug therapy (252) 252
astrocytes (251) 251
central nervous system neoplasms - pathology (250) 250
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Online Resources - Online (4) 4
Baycrest Hospital - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Law (Bora Laskin) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7477) 7477
French (26) 26
German (23) 23
Spanish (16) 16
Japanese (9) 9
Polish (4) 4
Italian (3) 3
Korean (3) 3
Portuguese (3) 3
Russian (3) 3
Chinese (2) 2
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Colorectal Disease, ISSN 1462-8910, 03/2019, Volume 21, Issue S1, pp. 32 - 36
The colorectal Clinical Nurse Specialist (CNS) makes an important contribution to the care of individuals diagnosed with a significant polyp and early... 
Treatment decision-making | Colorectal CNS role | Significant polyps and early colorectal cancer | Patient-centred care | Emotional support | Care and treatment | Nurses | Colorectal cancer
Journal Article
eBook
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 2, pp. 113 - 125
In 556 patients with previously untreated lung cancer bearing EGFR mutations, osimertinib and the first-generation EGFR inhibitors erlotinib and gefitinib had... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | PHASE-III | ACQUIRED-RESISTANCE | OPEN-LABEL | CNS RESPONSE | AZD9291 | CHEMOTHERAPY | ERLOTINIB | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Gefitinib | Lung Neoplasms - genetics | Double-Blind Method | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Survival Rate | Piperazines - therapeutic use | Carcinoma, Non-Small-Cell Lung - mortality | Piperazines - adverse effects | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Treatment outcome | Cancer patients | Care and treatment | Lung cancer, Non-small cell | Analysis | Tyrosine | Medical research | Epidermal growth factor receptors | Lung cancer | Clinical trials | Non-small cell lung carcinoma | Oncology | Metastasis | Gene deletion | Patients | Cancer therapies | Clinical outcomes | Chemotherapy | Epidermal growth factor | Clonal deletion | Protein-tyrosine kinase receptors | Protein-tyrosine kinase | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
2002, 2nd ed., ISBN 9780195137286, xvi, 606 p., [4] p. of plates
Book
Annals of Oncology, ISSN 0923-7534, 11/2018, Volume 29, Issue 11, pp. 2214 - 2222
Abstract Background The phase III ALEX study in patients with treatment-naive advanced anaplastic lymphoma kinase mutation-positive (ALK+) non-small-cell lung... 
ALK-positive | Alectinib | CNS | NSCLC | ONCOLOGY | BRAIN METASTASES | OPEN-LABEL | CHEMOTHERAPY | alectinib | Original articles
Journal Article
2012, 1st ed., Neurology in practice, ISBN 9780470655757, xii, 246
The aim of the Neurology in Practice series is to provide a clinical 'in the office' or 'at the bedside' guide to effective patient care for neurologists in... 
Central Nervous System Neoplasms | Nervous system | Central nervous system | Cancer | Brain
Book
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 82, pp. 27 - 33
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 12/2007, Volume 6, Issue 12, pp. 1833 - 1836
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 05/2018, Volume 13, Issue 5, pp. 715 - 720
Patients with brain metastases (BMs) arising from -mutated and anaplastic lymphoma kinase gene ( )-rearranged NSCLC have a favorable prognosis compared with... 
ALK | Stereotactic radiosurgery | Brain metastases | NSCLC | EGFR | SURVIVAL | JLGK0901 | ONCOLOGY | RESPIRATORY SYSTEM | EML4-ALK FUSION GENE | KINASE INHIBITOR | CNS RESPONSE | Index Medicus
Journal Article
Cancer Journal, ISSN 1528-9117, 01/2012, Volume 18, Issue 1, pp. 100 - 106
Journal Article
Journal Article
17.